![Mainz Biomed NV](/common/images/company/TG_4TO.png)
Mainz Biomed NV (4TO)
TG
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 281k | 493k | 577k | 529k | 895k |
Operating Income | -921k | -674k | -9.73M | -26.18M | -26.65M |
Pre Tax Income | -957k | -587k | -11.69M | -26.39M | -26.3M |
Net Income | -957k | -587k | -11.69M | -26.39M | -26.3M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.171 | -0.105 | -0.973 | -1.804 | -1.242 |
EBIT | -921k | -674k | -9.73M | -26.18M | -26.15M |
EBITDA | -867k | -614k | -9.66M | -25.92M | -25.78M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.